ONTOLOGY REPORT - ANNOTATIONS
| Term: | ethanol |
|
| Accession: | CHEBI:16236
|
browse the term
|
| Definition: | A primary alcohol that is ethane in which one of the hydrogens is substituted by a hydroxy group. |
| Synonyms: | related_synonym: | 1-hydroxyethane; Aethanol; Aethylalkohol; Alkohol; C2H5OH; C2H6O; CCO; Dehydrated ethanol; EtOH; Ethyl alcohol; InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3; InChIKey=LFQSCWFLJHTTHZ-UHFFFAOYSA-N; Methylcarbinol; [CH2Me(OH)]; [OEtH]; alcohol; alcohol etilico; alcool ethylique; etanol; hydroxyethane; spiritus vini |
| | alt_id: | CHEBI:14222; CHEBI:23978; CHEBI:30878; CHEBI:30880; CHEBI:42377; CHEBI:44594; CHEBI:4879 |
| | xref_casrn: | 64-17-5 |
| | xref: | Beilstein:1718733 "Beilstein Registry Number"; ChEBI:c0038 "UM-BBD compID"; ChEMBL:113618 "ChEMBL COMPOUND"; ChemIDplus:64-17-5 "CAS Registry Number"; CiteXplore:11046114 "PubMed citation"; CiteXplore:11090978 "PubMed citation"; CiteXplore:11198720 "PubMed citation"; CiteXplore:11200745 "PubMed citation"; CiteXplore:11262320 "PubMed citation"; CiteXplore:11303910 "PubMed citation"; CiteXplore:11333032 "PubMed citation"; CiteXplore:11505026 "PubMed citation"; CiteXplore:11590970 "PubMed citation"; CiteXplore:11728426 "PubMed citation"; CiteXplore:11750186 "PubMed citation"; CiteXplore:11754521 "PubMed citation"; CiteXplore:11810019 "PubMed citation"; CiteXplore:11826039 "PubMed citation"; CiteXplore:11981228 "PubMed citation"; CiteXplore:12824058 "PubMed citation"; CiteXplore:12829422 "PubMed citation"; CiteXplore:12888778 "PubMed citation"; CiteXplore:12946583 "PubMed citation"; CiteXplore:14674846 "PubMed citation"; CiteXplore:15019421 "PubMed citation"; CiteXplore:15239123 "PubMed citation"; CiteXplore:15285839 "PubMed citation"; CiteXplore:15464411 "PubMed citation"; CiteXplore:15465973 "PubMed citation"; CiteXplore:15749123 "PubMed citation"; CiteXplore:15900217 "PubMed citation"; CiteXplore:15902919 "PubMed citation"; CiteXplore:16084479 "PubMed citation"; CiteXplore:16133132 "PubMed citation"; CiteXplore:16352430 "PubMed citation"; CiteXplore:16390872 "PubMed citation"; CiteXplore:16737463 "PubMed citation"; CiteXplore:16891664 "PubMed citation"; CiteXplore:16934862 "PubMed citation"; CiteXplore:17043811 "PubMed citation"; CiteXplore:17190852 "PubMed citation"; CiteXplore:17663926 "PubMed citation"; CiteXplore:17687877 "PubMed citation"; CiteXplore:18095657 "PubMed citation"; CiteXplore:18249266 "PubMed citation"; CiteXplore:18320157 "PubMed citation"; CiteXplore:18347649 "PubMed citation"; CiteXplore:18408978 "PubMed citation"; CiteXplore:18411066 "PubMed citation"; CiteXplore:18456322 "PubMed citation"; CiteXplore:18513832 "PubMed citation"; CiteXplore:18922656 "PubMed citation"; CiteXplore:18925476 "PubMed citation"; CiteXplore:19280886 "PubMed citation"; CiteXplore:19359288 "PubMed citation"; CiteXplore:19384566 "PubMed citation"; CiteXplore:19458312 "PubMed citation"; CiteXplore:19851413 "PubMed citation"; CiteXplore:19901811 "PubMed citation"; CiteXplore:21600756 "PubMed citation"; CiteXplore:21762181 "PubMed citation"; CiteXplore:21881875 "PubMed citation"; CiteXplore:21967628 "PubMed citation"; CiteXplore:22019193 "PubMed citation"; CiteXplore:22222864 "PubMed citation"; CiteXplore:22261437 "PubMed citation"; CiteXplore:22286266 "PubMed citation"; CiteXplore:22306018 "PubMed citation"; CiteXplore:22331491 "PubMed citation"; CiteXplore:22336593 "PubMed citation"; DrugBank:DB00898 "DrugBank"; Gmelin:787 "Gmelin Registry Number"; HMDB:HMDB00108 "HMDB"; KEGG COMPOUND:64-17-5 "CAS Registry Number"; KEGG COMPOUND:C00469 "KEGG COMPOUND"; KEGG DRUG:D00068 "KEGG DRUG" |
| | xref_mesh: | MESH:D000431 |
| | xref: | MetaCyc:ETOH "MetaCyc"; MolBase:858 "MolBase"; MolBase:859 "MolBase"; NIST Chemistry WebBook:64-17-5 "CAS Registry Number"; PDBeChem:EOH "PDBeChem"; Reaxys:1718733 "Reaxys Registry Number"; Wikipedia:Ethanol "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:52092 |
|
|
ethanol
|
| G |
Abat |
4-aminobutyrate aminotransferase |
|
multiple interactions |
EXP |
10 |
7,040,725 |
7,137,154 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
multiple interactions |
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
increases expression |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
decreases expression |
EXP |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
multiple interactions |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
increases expression |
EXP |
6 |
108,017,574 |
108,024,387 |
RGD:6480464 |
CTD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
multiple interactions |
EXP |
6 |
108,017,574 |
108,024,387 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
multiple interactions |
EXP |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
EXP |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
increases expression |
EXP |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 homolog (yeast) |
|
decreases expression |
EXP |
13 |
37,861,558 |
37,904,589 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
decreases expression |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adat1 |
adenosine deaminase, tRNA-specific 1 |
|
decreases expression |
ISO |
19 |
41,902,820 |
41,926,545 |
RGD:6480464 |
CTD |
| G |
Adcy10 |
adenylate cyclase 10 (soluble) |
|
decreases expression |
EXP |
13 |
81,208,090 |
81,302,902 |
RGD:6480464 |
CTD |
| G |
Adcy10 |
adenylate cyclase 10 (soluble) |
|
multiple interactions |
EXP |
13 |
81,208,090 |
81,302,902 |
RGD:6480464 |
CTD |
| G |
Adcy2 |
adenylate cyclase 2 (brain) |
|
increases expression |
EXP |
17 |
4,543,466 |
5,040,433 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
increases expression |
EXP |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
decreases expression |
EXP |
11 |
67,290,968 |
67,437,468 |
RGD:6480464 |
CTD |
| G |
Adcy6 |
adenylate cyclase 6 |
|
decreases expression |
EXP |
7 |
137,339,933 |
137,360,020 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
increases expression |
EXP |
7 |
101,957,807 |
102,210,346 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
|
decreases expression |
EXP |
4 |
84,209,729 |
84,254,982 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases metabolic processing |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases expression |
EXP |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases metabolic processing |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
decreases expression |
ISO |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
multiple interactions |
ISO |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
increases oxidation |
ISO |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
affects oxidation |
ISO |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
increases oxidation |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects expression |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Aes |
amino-terminal enhancer of split |
|
multiple interactions |
EXP |
7 |
9,616,545 |
9,621,697 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
affects expression |
EXP |
5 |
172,999,420 |
173,020,764 |
RGD:6480464 |
CTD |
| G |
Agtpbp1 |
ATP/GTP binding protein 1 |
|
multiple interactions |
EXP |
17 |
11,040,339 |
11,155,923 |
RGD:6480464 |
CTD |
| G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
|
multiple interactions |
EXP |
2 |
59,713,365 |
59,754,876 |
RGD:6480464 |
CTD |
| G |
Ak3 |
adenylate kinase 3 |
|
decreases expression |
EXP |
1 |
232,658,879 |
232,684,083 |
RGD:6480464 |
CTD |
| G |
Ak5 |
adenylate kinase 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases expression |
EXP |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1c12 |
aldo-keto reductase family 1, member C12 |
|
multiple interactions |
EXP |
17 |
77,203,587 |
77,219,705 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects response to substance |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects response to substance |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases metabolic processing |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases response to substance |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects response to substance |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
multiple interactions |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases activity |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
increases expression |
ISO |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
decreases expression |
EXP |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
decreases expression |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
EXP |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
EXP |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
decreases expression |
EXP |
6 |
72,685,231 |
72,693,052 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
decreases expression |
EXP |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arrb1 |
arrestin, beta 1 |
|
decreases expression |
EXP |
1 |
156,871,564 |
156,937,540 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
affects expression |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
increases expression |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
multiple interactions |
EXP |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Ascl2 |
achaete-scute complex homolog 2 (Drosophila) |
|
multiple interactions |
EXP |
1 |
203,242,130 |
203,244,480 |
RGD:6480464 |
CTD |
| G |
Asgr1 |
asialoglycoprotein receptor 1 |
|
increases expression |
EXP |
10 |
56,899,266 |
56,903,173 |
RGD:6480464 |
CTD |
| G |
Asgr2 |
asialoglycoprotein receptor 2 |
|
increases expression |
EXP |
10 |
56,942,683 |
56,955,742 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
decreases expression |
EXP |
11 |
57,162,205 |
57,190,568 |
RGD:6480464 |
CTD |
| G |
Atn1 |
atrophin 1 |
|
multiple interactions |
EXP |
4 |
160,872,360 |
160,886,205 |
RGD:6480464 |
CTD |
| G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
affects expression |
EXP |
8 |
101,405,877 |
101,437,757 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
affects expression |
EXP |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
|
increases expression |
EXP |
10 |
84,788,650 |
84,791,230 |
RGD:6480464 |
CTD |
| G |
Atp6ap1 |
ATPase, H+ transporting, lysosomal accessory protein 1 |
|
decreases expression |
EXP |
X |
160,306,354 |
160,313,434 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
increases expression |
EXP |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
multiple interactions |
EXP |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects response to substance |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects localization |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects localization |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects localization |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases degradation |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
decreases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
increases expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer (apoptosis-inducing) |
|
multiple interactions |
EXP |
7 |
121,377,004 |
121,396,609 |
RGD:6480464 |
CTD |
| G |
Bpifa1 |
BPI fold containing family A, member 1 |
|
decreases expression |
ISO |
3 |
144,529,855 |
144,535,598 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
decreases expression |
EXP |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
Bst1 |
bone marrow stromal cell antigen 1 |
|
decreases expression |
EXP |
14 |
72,404,263 |
72,414,500 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
decreases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
decreases expression |
EXP |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
increases expression |
EXP |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
decreases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
affects response to substance |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm2 |
calmodulin 2 |
|
decreases expression |
EXP |
6 |
64,161,641 |
64,162,751 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
multiple interactions |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
decreases expression |
EXP |
18 |
56,879,247 |
56,948,537 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
decreases expression |
EXP |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
increases expression |
EXP |
2 |
223,840,650 |
224,108,082 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
decreases expression |
EXP |
15 |
3,729,433 |
3,786,060 |
RGD:6480464 |
CTD |
| G |
Cand1 |
cullin-associated and neddylation-dissociated 1 |
|
multiple interactions |
EXP |
7 |
58,461,205 |
58,499,092 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
affects expression |
EXP |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
affects expression |
EXP |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
increases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
multiple interactions |
EXP |
10 |
73,229,211 |
73,237,707 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
increases expression |
EXP |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
affects secretion |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
affects secretion |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd48 |
Cd48 molecule |
|
multiple interactions |
EXP |
13 |
87,684,545 |
87,708,091 |
RGD:6480464 |
CTD |
| G |
Cdc34 |
cell division cycle 34 |
|
decreases expression |
EXP |
7 |
11,534,543 |
11,539,941 |
RGD:6480464 |
CTD |
| G |
Cdc37l1 |
cell division cycle 37-like 1 |
|
decreases expression |
ISO |
1 |
232,624,609 |
232,652,549 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
decreases expression |
EXP |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
EXP |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdh17 |
cadherin 17 |
|
decreases expression |
EXP |
5 |
26,047,222 |
26,099,173 |
RGD:6480464 |
CTD |
| G |
Cdk11b |
cyclin-dependent kinase 11B |
|
multiple interactions |
EXP |
5 |
172,459,111 |
172,486,012 |
RGD:6480464 |
CTD |
| G |
Cdk20 |
cyclin-dependent kinase 20 |
|
affects response to substance |
ISO |
17 |
6,221,255 |
6,227,959 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases activity |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
EXP |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
multiple interactions |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
decreases expression |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chdh |
choline dehydrogenase |
|
increases expression |
EXP |
16 |
5,349,304 |
5,380,800 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
decreases expression |
EXP |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Clec10a |
C-type lectin domain family 10, member A |
|
decreases expression |
EXP |
10 |
56,998,778 |
57,002,953 |
RGD:6480464 |
CTD |
| G |
Clec4f |
C-type lectin domain family 4, member F |
|
multiple interactions |
EXP |
4 |
117,839,863 |
117,849,584 |
RGD:6480464 |
CTD |
| G |
Clk3 |
CDC-like kinase 3 |
|
decreases expression |
EXP |
8 |
61,519,196 |
61,532,816 |
RGD:6480464 |
CTD |
| G |
Clns1a |
chloride channel, nucleotide-sensitive, 1A |
|
increases expression |
EXP |
1 |
154,946,713 |
154,966,947 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects expression |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
affects response to substance |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
decreases expression |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
decreases expression |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
decreases expression |
EXP |
1 |
187,464,579 |
187,465,301 |
RGD:6480464 |
CTD |
| G |
Cox6c |
cytochrome c oxidase, subunit VIc |
|
increases expression |
EXP |
7 |
71,465,790 |
71,478,524 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1 (pancreatic) |
|
multiple interactions |
EXP |
4 |
57,549,260 |
57,555,361 |
RGD:6480464 |
CTD |
| G |
Cpa2 |
carboxypeptidase A2 (pancreatic) |
|
multiple interactions |
EXP |
4 |
57,452,111 |
57,475,357 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
increases expression |
EXP |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
decreases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
decreases expression |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
decreases expression |
EXP |
5 |
60,040,874 |
60,045,512 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
decreases expression |
EXP |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
EXP |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
increases expression |
EXP |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
affects expression |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases expression |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Crybb3 |
crystallin, beta B3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Crybb3 |
crystallin, beta B3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
decreases secretion |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
EXP |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctse |
cathepsin E |
|
increases expression |
EXP |
13 |
44,582,911 |
44,605,241 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
affects expression |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases secretion |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases secretion |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
increases expression |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
decreases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
decreases expression |
EXP |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases response to substance |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects activity |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
multiple interactions |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
increases expression |
EXP |
15 |
32,285,592 |
32,305,885 |
RGD:6480464 |
CTD |
| G |
Dao |
D-amino-acid oxidase |
|
increases expression |
EXP |
12 |
43,627,593 |
43,648,332 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
increases expression |
EXP |
7 |
10,007,997 |
10,016,365 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
multiple interactions |
EXP |
X |
34,596,262 |
34,672,383 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
decreases expression |
EXP |
X |
34,596,262 |
34,672,383 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddn |
dendrin |
|
multiple interactions |
EXP |
7 |
137,572,548 |
137,576,530 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
ISO |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
increases expression |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
multiple interactions |
EXP |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
decreases expression |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
increases expression |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Dlg4 |
discs, large homolog 4 (Drosophila) |
|
increases expression |
EXP |
10 |
56,864,459 |
56,890,626 |
RGD:6480464 |
CTD |
| G |
Dlg4 |
discs, large homolog 4 (Drosophila) |
|
multiple interactions |
EXP |
10 |
56,864,459 |
56,890,626 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
multiple interactions |
EXP |
1 |
190,378,428 |
190,470,536 |
RGD:6480464 |
CTD |
| G |
Dnm2 |
dynamin 2 |
|
decreases expression |
EXP |
8 |
20,527,130 |
20,610,749 |
RGD:6480464 |
CTD |
| G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
decreases expression |
ISO |
9 |
9,865,096 |
9,867,833 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
decreases expression |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
affects response to substance |
ISO |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
multiple interactions |
EXP |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
affects activity |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
increases expression |
ISO |
5 |
140,742,686 |
140,747,580 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eea1 |
early endosome antigen 1 |
|
decreases expression |
EXP |
7 |
33,294,184 |
33,396,666 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
EXP |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
multiple interactions |
EXP |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
increases expression |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
|
decreases expression |
EXP |
6 |
25,159,823 |
25,165,561 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif5b |
eukaryotic translation initiation factor 5B |
|
increases expression |
EXP |
9 |
36,937,415 |
36,993,650 |
RGD:6480464 |
CTD |
| G |
Eif5b-ps1 |
eukaryotic translation initiation factor 5B, pseudogene 1 |
|
increases expression |
EXP |
19 |
37,343,402 |
37,347,524 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
EXP |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases expression |
EXP |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
increases expression |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
affects expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
EXP |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
increases expression |
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
EXP |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Ewsr1 |
Ewing sarcoma breakpoint region 1 |
|
increases expression |
ISO |
14 |
85,730,483 |
85,758,958 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
EXP |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
multiple interactions |
EXP |
2 |
219,591,502 |
219,605,097 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fabp6 |
fatty acid binding protein 6, ileal |
|
increases expression |
EXP |
10 |
28,694,773 |
28,699,442 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases expression |
ISO |
4 |
149,424,558 |
149,500,006 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases expression |
ISO |
4 |
149,424,558 |
149,500,006 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fcgrt |
Fc fragment of IgG, receptor, transporter, alpha |
|
increases expression |
EXP |
1 |
95,566,717 |
95,575,645 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
multiple interactions |
EXP |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
EXP |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
decreases expression |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
increases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Flnc |
filamin C, gamma |
|
multiple interactions |
EXP |
4 |
56,313,707 |
56,341,400 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
increases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
decreases expression |
ISO |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
increases expression |
ISO |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
increases expression |
EXP |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
EXP |
1 |
78,668,497 |
78,673,330 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
decreases expression |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Fut4 |
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) |
|
increases expression |
ISO |
8 |
11,541,524 |
11,545,485 |
RGD:6480464 |
CTD |
| G |
Fut4 |
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) |
|
multiple interactions |
ISO |
8 |
11,541,524 |
11,545,485 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
increases phosphorylation |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
increases activity |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
affects response to substance |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
decreases expression |
EXP |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
increases expression |
EXP |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
decreases expression |
EXP |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
increases expression |
EXP |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
multiple interactions |
EXP |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabrb1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
|
multiple interactions |
ISO |
14 |
38,530,259 |
39,005,615 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
affects response to substance |
ISO |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
affects response to substance |
EXP |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
increases expression |
EXP |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
increases expression |
EXP |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
decreases expression |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
increases expression |
EXP |
17 |
79,991,587 |
80,011,574 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
increases phosphorylation |
ISO |
15 |
42,472,793 |
42,519,569 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
multiple interactions |
ISO |
15 |
42,472,793 |
42,519,569 |
RGD:6480464 |
CTD |
| G |
Gbp2 |
guanylate binding protein 2, interferon-inducible |
|
multiple interactions |
EXP |
2 |
240,523,000 |
240,541,078 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
affects expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfra1 |
GDNF family receptor alpha 1 |
|
decreases expression |
EXP |
1 |
264,614,329 |
264,875,486 |
RGD:6480464 |
CTD |
| G |
Ggcx |
gamma-glutamyl carboxylase |
|
decreases expression |
EXP |
4 |
105,719,323 |
105,735,037 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
affects folding |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Glra2 |
glycine receptor, alpha 2 |
|
decreases expression |
EXP |
X |
49,755,521 |
49,978,214 |
RGD:6480464 |
CTD |
| G |
Glra2 |
glycine receptor, alpha 2 |
|
multiple interactions |
EXP |
X |
49,755,521 |
49,978,214 |
RGD:6480464 |
CTD |
| G |
Glra3 |
glycine receptor, alpha 3 |
|
decreases expression |
EXP |
16 |
37,741,192 |
37,854,773 |
RGD:6480464 |
CTD |
| G |
Glrb |
glycine receptor, beta |
|
increases expression |
EXP |
2 |
172,451,807 |
172,522,841 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gm2a |
GM2 ganglioside activator |
|
increases expression |
ISO |
10 |
40,502,175 |
40,514,708 |
RGD:6480464 |
CTD |
| G |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
|
decreases expression |
EXP |
7 |
9,636,748 |
9,662,492 |
RGD:6480464 |
CTD |
| G |
Gna12 |
guanine nucleotide binding protein (G protein) alpha 12 |
|
increases expression |
EXP |
12 |
14,275,708 |
14,354,843 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
increases expression |
EXP |
1 |
219,906,120 |
219,983,252 |
RGD:6480464 |
CTD |
| G |
Gna15 |
guanine nucleotide binding protein, alpha 15 |
|
increases expression |
EXP |
7 |
9,669,956 |
9,689,442 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
increases expression |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
increases expression |
EXP |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
increases expression |
EXP |
18 |
63,595,606 |
63,735,803 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
decreases expression |
EXP |
19 |
11,472,083 |
11,623,600 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
multiple interactions |
EXP |
19 |
11,472,083 |
11,623,600 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
increases expression |
EXP |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
increases expression |
EXP |
20 |
14,148,003 |
14,174,136 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
multiple interactions |
EXP |
20 |
14,148,003 |
14,174,136 |
RGD:6480464 |
CTD |
| G |
Gnb2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
|
increases expression |
EXP |
12 |
19,597,312 |
19,602,329 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
EXP |
10 |
34,067,237 |
34,072,593 |
RGD:6480464 |
CTD |
| G |
Gnb4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
|
increases expression |
EXP |
2 |
118,791,192 |
118,827,413 |
RGD:6480464 |
CTD |
| G |
Gnb5 |
guanine nucleotide binding protein (G protein), beta 5 |
|
increases expression |
EXP |
8 |
80,128,787 |
80,169,629 |
RGD:6480464 |
CTD |
| G |
Gng10 |
guanine nucleotide binding protein (G protein), gamma 10 |
|
decreases expression |
EXP |
5 |
77,083,335 |
77,090,218 |
RGD:6480464 |
CTD |
| G |
Gng10 |
guanine nucleotide binding protein (G protein), gamma 10 |
|
multiple interactions |
EXP |
5 |
77,083,335 |
77,090,218 |
RGD:6480464 |
CTD |
| G |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
|
decreases expression |
EXP |
1 |
211,507,640 |
211,509,406 |
RGD:6480464 |
CTD |
| G |
Gng5 |
guanine nucleotide binding protein (G protein), gamma 5 |
|
decreases expression |
EXP |
2 |
244,702,876 |
244,711,373 |
RGD:6480464 |
CTD |
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
increases expression |
EXP |
7 |
10,203,112 |
10,271,719 |
RGD:6480464 |
CTD |
| G |
Gng8 |
guanine nucleotide binding protein (G protein), gamma 8 |
|
decreases expression |
EXP |
1 |
77,221,378 |
77,223,313 |
RGD:6480464 |
CTD |
| G |
Gnpat |
glyceronephosphate O-acyltransferase |
|
increases expression |
EXP |
19 |
55,033,777 |
55,059,491 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
increases expression |
EXP |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
decreases expression |
ISO |
7 |
138,458,875 |
138,466,266 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
multiple interactions |
EXP |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Gphn |
gephyrin |
|
increases expression |
EXP |
6 |
100,833,004 |
101,302,957 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases expression |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
multiple interactions |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
multiple interactions |
EXP |
3 |
46,832,380 |
46,952,670 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
decreases expression |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
affects expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
multiple interactions |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA 4 |
|
decreases expression |
EXP |
8 |
956,325 |
1,438,314 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
increases expression |
EXP |
16 |
10,473,353 |
11,202,161 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
multiple interactions |
EXP |
16 |
10,473,353 |
11,202,161 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
decreases expression |
EXP |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
multiple interactions |
EXP |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
|
decreases expression |
EXP |
11 |
27,703,874 |
28,106,450 |
RGD:6480464 |
CTD |
| G |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
|
multiple interactions |
EXP |
11 |
27,703,874 |
28,106,450 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
increases expression |
EXP |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
|
decreases expression |
EXP |
5 |
144,842,374 |
145,058,047 |
RGD:6480464 |
CTD |
| G |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
|
decreases expression |
EXP |
8 |
45,510,258 |
45,681,279 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 |
|
increases expression |
EXP |
1 |
80,313,801 |
80,384,390 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
decreases expression |
EXP |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grin2d |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
|
decreases expression |
EXP |
1 |
96,308,548 |
96,345,931 |
RGD:6480464 |
CTD |
| G |
Grin2d |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
|
multiple interactions |
EXP |
1 |
96,308,548 |
96,345,931 |
RGD:6480464 |
CTD |
| G |
Grin3a |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
|
decreases expression |
EXP |
5 |
66,406,451 |
66,602,353 |
RGD:6480464 |
CTD |
| G |
Grin3b |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
|
decreases expression |
EXP |
7 |
11,243,973 |
11,250,311 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
decreases expression |
EXP |
7 |
114,277,208 |
114,280,339 |
RGD:6480464 |
CTD |
| G |
Grip1 |
glutamate receptor interacting protein 1 |
|
affects expression |
EXP |
7 |
59,157,276 |
59,306,131 |
RGD:6480464 |
CTD |
| G |
Grip1 |
glutamate receptor interacting protein 1 |
|
decreases expression |
EXP |
7 |
59,157,276 |
59,306,131 |
RGD:6480464 |
CTD |
| G |
Grip2 |
glutamate receptor interacting protein 2 |
|
increases expression |
EXP |
4 |
125,951,936 |
126,001,803 |
RGD:6480464 |
CTD |
| G |
Gripap1 |
GRIP1 associated protein 1 |
|
multiple interactions |
EXP |
X |
26,713,439 |
26,743,461 |
RGD:6480464 |
CTD |
| G |
Gripap1 |
GRIP1 associated protein 1 |
|
increases expression |
EXP |
X |
26,713,439 |
26,743,461 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
decreases expression |
EXP |
1 |
5,318,617 |
5,744,593 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
decreases expression |
EXP |
4 |
20,745,424 |
22,118,097 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
multiple interactions |
EXP |
4 |
20,745,424 |
22,118,097 |
RGD:6480464 |
CTD |
| G |
Grm4 |
glutamate receptor, metabotropic 4 |
|
decreases expression |
EXP |
20 |
5,627,733 |
5,727,274 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
increases expression |
EXP |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
multiple interactions |
EXP |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
decreases expression |
EXP |
10 |
36,421,806 |
36,436,909 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
multiple interactions |
EXP |
10 |
36,421,806 |
36,436,909 |
RGD:6480464 |
CTD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
increases expression |
EXP |
4 |
146,952,340 |
147,270,225 |
RGD:6480464 |
CTD |
| G |
Grm8 |
glutamate receptor, metabotropic 8 |
|
decreases expression |
EXP |
4 |
53,976,781 |
54,902,331 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
increases expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
increases expression |
EXP |
20 |
13,595,934 |
13,603,087 |
RGD:6480464 |
CTD |
| G |
Gtf2a2 |
general transcription factor IIA, 2 |
|
increases expression |
EXP |
8 |
74,447,866 |
74,456,735 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
multiple interactions |
EXP |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
Gucy2g |
guanylate cyclase 2G |
|
multiple interactions |
EXP |
1 |
261,500,922 |
261,542,254 |
RGD:6480464 |
CTD |
| G |
Gusb |
glucuronidase, beta |
|
increases expression |
EXP |
12 |
27,744,409 |
27,757,755 |
RGD:6480464 |
CTD |
| G |
Gzma |
granzyme A |
|
multiple interactions |
ISO |
2 |
44,488,295 |
44,500,128 |
RGD:6480464 |
CTD |
| G |
Gzmbl2 |
Granzyme B-like 2 |
|
multiple interactions |
ISO |
15 |
35,061,676 |
35,074,048 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
multiple interactions |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
increases expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
decreases expression |
EXP |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hgs |
hepatocyte growth factor-regulated tyrosine kinase substrate |
|
decreases expression |
EXP |
10 |
109,861,289 |
109,869,587 |
RGD:6480464 |
CTD |
| G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
|
decreases expression |
EXP |
4 |
80,850,300 |
80,948,361 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
affects expression |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
decreases expression |
EXP |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
multiple interactions |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
increases expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
multiple interactions |
EXP |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases activity |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
decreases expression |
EXP |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
increases expression |
ISO |
14 |
10,861,054 |
10,864,322 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Homer2 |
homer homolog 2 (Drosophila) |
|
decreases expression |
EXP |
1 |
137,827,128 |
137,933,089 |
RGD:6480464 |
CTD |
| G |
Hps1 |
Hermansky-Pudlak syndrome 1 homolog (human) |
|
affects expression |
ISO |
1 |
248,109,643 |
248,134,450 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
multiple interactions |
EXP |
7 |
1,118,183 |
1,137,670 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
affects response to substance |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
increases expression |
EXP |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
decreases expression |
EXP |
1 |
85,599,075 |
85,601,214 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
multiple interactions |
ISO |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3b |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
|
multiple interactions |
ISO |
8 |
52,198,432 |
52,228,238 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
multiple interactions |
EXP |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
affects expression |
EXP |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
affects expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Ikzf4 |
IKAROS family zinc finger 4 |
|
decreases expression |
ISO |
7 |
1,928,510 |
1,948,712 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
increases expression |
ISO |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
affects secretion |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
affects secretion |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
increases expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
multiple interactions |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
decreases expression |
EXP |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
increases expression |
EXP |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
increases expression |
EXP |
4 |
83,934,018 |
83,938,314 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
multiple interactions |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases phosphorylation |
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
decreases expression |
EXP |
1 |
136,552,358 |
136,642,545 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
multiple interactions |
EXP |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
affects phosphorylation |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin, alpha 1 |
|
decreases expression |
EXP |
2 |
47,107,849 |
47,206,261 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
increases response to substance |
EXP |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
EXP |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
increases expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
multiple interactions |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
increases expression |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
|
multiple interactions |
EXP |
2 |
202,472,638 |
202,474,215 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
decreases expression |
EXP |
1 |
95,066,641 |
95,080,847 |
RGD:6480464 |
CTD |
| G |
Kcnh4 |
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
|
decreases expression |
EXP |
10 |
89,677,981 |
89,697,799 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
multiple interactions |
ISO |
3 |
37,068,672 |
37,256,990 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
multiple interactions |
EXP |
3 |
37,068,672 |
37,256,990 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
multiple interactions |
ISO |
11 |
35,025,118 |
35,116,500 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
increases activity |
ISO |
11 |
35,025,118 |
35,116,500 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
multiple interactions |
EXP |
11 |
35,025,118 |
35,116,500 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
increases activity |
ISO |
15 |
575,136 |
950,275 |
RGD:6480464 |
CTD |
| G |
Kdm3a |
lysine (K)-specific demethylase 3A |
|
decreases expression |
EXP |
4 |
104,866,501 |
104,911,355 |
RGD:6480464 |
CTD |
| G |
Kifc3 |
kinesin family member C3 |
|
multiple interactions |
EXP |
19 |
10,335,789 |
10,354,364 |
RGD:6480464 |
CTD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
decreases expression |
ISO |
4 |
166,914,786 |
166,922,659 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
L1cam |
L1 cell adhesion molecule |
|
multiple interactions |
ISO |
X |
159,784,792 |
159,801,553 |
RGD:6480464 |
CTD |
| G |
L1cam |
L1 cell adhesion molecule |
|
decreases activity |
ISO |
X |
159,784,792 |
159,801,553 |
RGD:6480464 |
CTD |
| G |
L3hypdh |
L-3-hydroxyproline dehydratase (trans-) |
|
multiple interactions |
EXP |
6 |
94,270,120 |
94,280,916 |
RGD:6480464 |
CTD |
| G |
Lactb2 |
lactamase, beta 2 |
|
multiple interactions |
EXP |
5 |
4,770,321 |
4,793,420 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
decreases expression |
EXP |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
decreases expression |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
EXP |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
increases response to substance |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lgals9 |
lectin, galactoside-binding, soluble, 9 |
|
increases expression |
EXP |
10 |
65,129,006 |
65,152,052 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
multiple interactions |
EXP |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
Lman1 |
lectin, mannose-binding, 1 |
|
increases expression |
EXP |
18 |
62,504,296 |
62,524,151 |
RGD:6480464 |
CTD |
| G |
LOC100361700 |
proline rich region 18-like |
|
decreases expression |
ISO |
1 |
47,040,962 |
47,043,972 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
multiple interactions |
EXP |
8 |
62,083,052 |
62,106,827 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
increases expression |
ISO |
15 |
49,982,103 |
50,068,902 |
RGD:6480464 |
CTD |
| G |
Lphn2 |
latrophilin 2 |
|
increases expression |
EXP |
2 |
247,060,645 |
247,201,904 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
decreases expression |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
multiple interactions |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
affects expression |
EXP |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
EXP |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
affects expression |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
decreases expression |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
increases expression |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
increases expression |
EXP |
10 |
47,075,270 |
47,096,617 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases phosphorylation |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk12 |
mitogen-activated protein kinase 12 |
|
increases expression |
EXP |
7 |
127,430,881 |
127,441,274 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
affects expression |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
affects expression |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mat2a |
methionine adenosyltransferase II, alpha |
|
decreases expression |
ISO |
4 |
105,739,943 |
105,745,472 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
affects expression |
EXP |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
multiple interactions |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
decreases expression |
EXP |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
multiple interactions |
EXP |
14 |
81,745,997 |
81,748,824 |
RGD:6480464 |
CTD |
| G |
Mfsd12 |
major facilitator superfamily domain containing 12 |
|
multiple interactions |
EXP |
7 |
9,831,853 |
9,838,324 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
increases expression |
EXP |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mip |
major intrinsic protein of lens fiber |
|
multiple interactions |
EXP |
7 |
1,509,023 |
1,516,275 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
decreases expression |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
decreases expression |
ISO |
7 |
10,550,040 |
10,561,100 |
RGD:6480464 |
CTD |
| G |
Mlx |
MLX, MAX dimerization protein |
|
increases expression |
EXP |
10 |
90,104,233 |
90,108,952 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
decreases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp23 |
matrix metallopeptidase 23 |
|
decreases expression |
EXP |
5 |
172,486,916 |
172,489,459 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mnf1 |
mitochondrial nucleoid factor 1 |
|
multiple interactions |
EXP |
20 |
5,358,000 |
5,369,728 |
RGD:6480464 |
CTD |
| G |
Mpdz |
multiple PDZ domain protein |
|
multiple interactions |
EXP |
5 |
100,008,984 |
100,170,202 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
|
multiple interactions |
EXP |
10 |
86,046,541 |
86,058,364 |
RGD:6480464 |
CTD |
| G |
Mrps16 |
mitochondrial ribosomal protein S16 |
|
increases expression |
ISO |
15 |
4,147,260 |
4,149,662 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
multiple interactions |
EXP |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mtmr7 |
myotubularin related protein 7 |
|
multiple interactions |
EXP |
16 |
54,982,204 |
55,073,152 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtpn |
myotrophin |
|
increases expression |
EXP |
4 |
62,896,762 |
62,924,175 |
RGD:6480464 |
CTD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
multiple interactions |
ISO |
2 |
235,613,710 |
235,654,848 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
decreases expression |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
decreases expression |
EXP |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Myl3 |
myosin, light chain 3, alkali; ventricular, skeletal, slow |
|
decreases expression |
EXP |
8 |
115,140,705 |
115,146,827 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
increases activity |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
multiple interactions |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylpf |
myosin light chain, phosphorylatable, fast skeletal muscle |
|
decreases expression |
ISO |
1 |
186,471,805 |
186,474,560 |
RGD:6480464 |
CTD |
| G |
Myo1e |
myosin IE |
|
decreases expression |
EXP |
8 |
74,680,727 |
74,884,376 |
RGD:6480464 |
CTD |
| G |
Myo5b |
myosin Vb |
|
multiple interactions |
EXP |
18 |
71,381,068 |
71,580,824 |
RGD:6480464 |
CTD |
| G |
Ncl |
nucleolin |
|
multiple interactions |
EXP |
9 |
85,112,752 |
85,121,276 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
multiple interactions |
EXP |
1 |
180,908,331 |
180,921,734 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
affects expression |
ISO |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Neurl2 |
neuralized homolog 2 (Drosophila) |
|
multiple interactions |
EXP |
3 |
155,863,669 |
155,865,955 |
RGD:6480464 |
CTD |
| G |
Nfatc4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
|
decreases expression |
EXP |
15 |
33,969,774 |
33,978,848 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression |
EXP |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects expression |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 |
|
multiple interactions |
ISO |
1 |
251,521,559 |
251,527,815 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfyc |
nuclear transcription factor-Y gamma |
|
decreases expression |
EXP |
5 |
141,349,685 |
141,407,900 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nptxr |
neuronal pentraxin receptor |
|
affects expression |
EXP |
7 |
118,023,653 |
118,041,729 |
RGD:6480464 |
CTD |
| G |
Nptxr |
neuronal pentraxin receptor |
|
increases expression |
EXP |
7 |
118,023,653 |
118,041,729 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression |
EXP |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
decreases expression |
EXP |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
decreases expression |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
decreases expression |
EXP |
19 |
32,527,752 |
32,875,369 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
increases expression |
EXP |
19 |
32,527,752 |
32,875,369 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
increases response to substance |
ISO |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Nrg4 |
neuregulin 4 |
|
increases expression |
ISO |
8 |
58,764,526 |
58,830,666 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
decreases expression |
EXP |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Nsfl1c |
NSFL1 (p97) cofactor (p47) |
|
decreases expression |
EXP |
3 |
141,799,286 |
141,823,762 |
RGD:6480464 |
CTD |
| G |
Nt5e |
5' nucleotidase, ecto |
|
increases expression |
EXP |
8 |
93,591,630 |
93,635,481 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
increases response to substance |
EXP |
7 |
40,474,654 |
40,484,058 |
RGD:6480464 |
CTD |
| G |
Nup98 |
nucleoporin 98 |
|
decreases expression |
EXP |
1 |
159,598,048 |
159,696,720 |
RGD:6480464 |
CTD |
| G |
Nxph3 |
neurexophilin 3 |
|
decreases expression |
ISO |
10 |
84,202,769 |
84,206,435 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
decreases expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
increases expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Olr1226 |
olfactory receptor 1226 |
|
decreases expression |
EXP |
8 |
40,432,178 |
40,433,119 |
RGD:6480464 |
CTD |
| G |
Olr59 |
olfactory receptor 59 |
|
decreases expression |
EXP |
1 |
160,607,895 |
160,613,826 |
RGD:6480464 |
CTD |
| G |
Oma1 |
zinc metallopeptidase homolog (S. cerevisiae) |
|
multiple interactions |
EXP |
5 |
124,261,197 |
124,314,715 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
decreases expression |
ISO |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
multiple interactions |
ISO |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases response to substance |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
affects response to substance |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Otx1 |
orthodenticle homeobox 1 |
|
decreases expression |
EXP |
14 |
102,721,413 |
102,724,748 |
RGD:6480464 |
CTD |
| G |
P2rx6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
|
decreases expression |
EXP |
11 |
85,431,257 |
85,441,293 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
EXP |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
decreases expression |
EXP |
7 |
121,484,248 |
121,546,498 |
RGD:6480464 |
CTD |
| G |
Pacsin3 |
protein kinase C and casein kinase substrate in neurons 3 |
|
increases expression |
EXP |
3 |
75,611,040 |
75,619,605 |
RGD:6480464 |
CTD |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
decreases expression |
EXP |
1 |
155,057,622 |
155,174,714 |
RGD:6480464 |
CTD |
| G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
|
decreases expression |
EXP |
9 |
96,893,071 |
97,047,523 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases expression |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha |
|
increases expression |
EXP |
20 |
28,448,703 |
28,454,184 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcm1 |
pericentriolar material 1 |
|
decreases expression |
EXP |
16 |
54,321,572 |
54,419,178 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcyt2 |
phosphate cytidylyltransferase 2, ethanolamine |
|
decreases expression |
EXP |
10 |
110,002,023 |
110,009,335 |
RGD:6480464 |
CTD |
| G |
Pdcl |
phosducin-like |
|
increases expression |
EXP |
3 |
17,107,429 |
17,116,454 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
increases expression |
EXP |
1 |
172,409,282 |
172,577,108 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
increases expression |
EXP |
8 |
20,192,677 |
20,241,557 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
affects response to substance |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
EXP |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
decreases expression |
EXP |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
increases expression |
EXP |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
decreases expression |
EXP |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
multiple interactions |
EXP |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
multiple interactions |
ISO |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
decreases expression |
ISO |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
affects response to substance |
ISO |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pdzd11 |
PDZ domain containing 11 |
|
multiple interactions |
EXP |
X |
88,621,186 |
88,624,218 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
decreases expression |
ISO |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
multiple interactions |
ISO |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
affects expression |
ISO |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
multiple interactions |
EXP |
1 |
135,513,735 |
135,520,816 |
RGD:6480464 |
CTD |
| G |
Pfdn5 |
prefoldin subunit 5 |
|
decreases expression |
ISO |
7 |
141,075,469 |
141,080,207 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
decreases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phkg2 |
phosphorylase kinase, gamma 2 (testis) |
|
decreases expression |
EXP |
1 |
186,858,077 |
186,870,601 |
RGD:6480464 |
CTD |
| G |
Pi4kb |
phosphatidylinositol 4-kinase, catalytic, beta |
|
decreases expression |
EXP |
2 |
189,874,613 |
189,906,640 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
increases expression |
EXP |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
increases expression |
EXP |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
|
increases expression |
EXP |
8 |
103,886,682 |
103,957,112 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
affects expression |
EXP |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
increases expression |
EXP |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
multiple interactions |
EXP |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pik3r2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
|
increases expression |
EXP |
16 |
19,171,101 |
19,179,650 |
RGD:6480464 |
CTD |
| G |
Pik3r3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
decreases expression |
EXP |
5 |
136,497,494 |
136,566,473 |
RGD:6480464 |
CTD |
| G |
Pik3r3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
multiple interactions |
EXP |
5 |
136,497,494 |
136,566,473 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pla2g16 |
phospholipase A2, group XVI |
|
multiple interactions |
EXP |
1 |
210,281,109 |
210,315,280 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
EXP |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
decreases expression |
EXP |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
EXP |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plcd1 |
phospholipase C, delta 1 |
|
increases expression |
EXP |
8 |
124,023,090 |
124,052,193 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
decreases expression |
EXP |
1 |
242,794,858 |
243,103,437 |
RGD:6480464 |
CTD |
| G |
Plcg1 |
phospholipase C, gamma 1 |
|
multiple interactions |
ISO |
3 |
151,522,949 |
151,553,998 |
RGD:6480464 |
CTD |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
increases expression |
EXP |
19 |
47,875,572 |
47,947,573 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
decreases expression |
EXP |
9 |
54,207,542 |
54,546,228 |
RGD:6480464 |
CTD |
| G |
Plcl1 |
phospholipase C-like 1 |
|
multiple interactions |
EXP |
9 |
54,207,542 |
54,546,228 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
ISO |
8 |
97,525,279 |
97,623,152 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
decreases expression |
EXP |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
decreases expression |
ISO |
12 |
11,004,507 |
11,028,754 |
RGD:6480464 |
CTD |
| G |
Pnck |
pregnancy upregulated non-ubiquitously expressed CaM kinase |
|
multiple interactions |
EXP |
X |
45,741,127 |
45,741,920 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
multiple interactions |
EXP |
5 |
49,544,328 |
49,547,367 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases secretion |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
decreases expression |
ISO |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases activity |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppib |
peptidylprolyl isomerase B |
|
increases expression |
EXP |
8 |
70,343,463 |
70,349,320 |
RGD:6480464 |
CTD |
| G |
Ppp2r2a |
protein phosphatase 2, regulatory subunit B, alpha |
|
decreases expression |
EXP |
15 |
46,546,447 |
46,605,977 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
multiple interactions |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
increases expression |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
decreases expression |
EXP |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
decreases expression |
EXP |
15 |
3,986,290 |
4,030,352 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
multiple interactions |
EXP |
15 |
3,986,290 |
4,030,352 |
RGD:6480464 |
CTD |
| G |
Rab1b |
RAB1B, member RAS oncogene family |
|
affects expression |
EXP |
1 |
207,720,833 |
207,727,458 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
EXP |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbpms |
RNA binding protein with multiple splicing |
|
increases expression |
ISO |
16 |
62,009,626 |
62,163,466 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Resp18 |
regulated endocrine-specific protein 18 |
|
multiple interactions |
EXP |
9 |
74,551,809 |
74,558,151 |
RGD:6480464 |
CTD |
| G |
Rev1 |
REV1, polymerase (DNA directed) |
|
multiple interactions |
EXP |
9 |
36,994,269 |
37,042,663 |
RGD:6480464 |
CTD |
| G |
RGD1305347 |
similar to RIKEN cDNA 2610528J11 |
|
multiple interactions |
EXP |
5 |
138,994,624 |
138,997,776 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
increases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
increases expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnpep |
arginyl aminopeptidase (aminopeptidase B) |
|
multiple interactions |
EXP |
13 |
48,267,923 |
48,286,295 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
decreases expression |
EXP |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases phosphorylation |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
decreases expression |
ISO |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
RT1-EC2 |
RT1 class Ib, locus EC2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RT1-N1 |
RT1 class Ib, locus N1 |
|
multiple interactions |
EXP |
20 |
2,785,625 |
2,788,804 |
RGD:6480464 |
CTD |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
multiple interactions |
EXP |
20 |
2,815,943 |
2,820,644 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
increases expression |
ISO |
20 |
4,954,336 |
4,960,880 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
increases expression |
ISO |
13 |
83,256,823 |
83,298,724 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
increases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
multiple interactions |
EXP |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
EXP |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
multiple interactions |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scg3 |
secretogranin III |
|
decreases expression |
ISO |
8 |
80,467,921 |
80,514,192 |
RGD:6480464 |
CTD |
| G |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
|
multiple interactions |
EXP |
3 |
48,438,725 |
48,518,893 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
multiple interactions |
EXP |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
decreases expression |
EXP |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
EXP |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
|
increases expression |
EXP |
2 |
147,866,072 |
147,870,096 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
decreases expression |
EXP |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sh2b1 |
SH2B adaptor protein 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Shh |
sonic hedgehog |
|
decreases expression |
ISO |
4 |
2,200,504 |
2,209,657 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases expression |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc10a2 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
|
decreases expression |
EXP |
16 |
89,939,295 |
89,961,444 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
decreases expression |
EXP |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
|
decreases expression |
EXP |
1 |
101,425,975 |
101,466,023 |
RGD:6480464 |
CTD |
| G |
Slc17a7 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
|
decreases expression |
EXP |
1 |
95,640,743 |
95,651,938 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
decreases expression |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
increases expression |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
affects expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
increases expression |
EXP |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
multiple interactions |
EXP |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
decreases expression |
EXP |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
decreases expression |
EXP |
7 |
12,393,284 |
12,419,893 |
RGD:6480464 |
CTD |
| G |
Slc20a2 |
solute carrier family 20 (phosphate transporter), member 2 |
|
increases expression |
EXP |
16 |
73,948,917 |
74,174,391 |
RGD:6480464 |
CTD |
| G |
Slc25a18 |
solute carrier family 25 (glutamate carrier), member 18 |
|
decreases expression |
EXP |
4 |
157,182,532 |
157,202,851 |
RGD:6480464 |
CTD |
| G |
Slc25a22 |
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 |
|
decreases expression |
EXP |
1 |
201,617,689 |
201,625,537 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
decreases expression |
EXP |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
EXP |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
decreases expression |
EXP |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
multiple interactions |
EXP |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
|
increases expression |
EXP |
3 |
149,342,399 |
149,347,124 |
RGD:6480464 |
CTD |
| G |
Slc34a3 |
solute carrier family 34 (sodium phosphate), member 3 |
|
decreases expression |
EXP |
3 |
3,393,502 |
3,399,042 |
RGD:6480464 |
CTD |
| G |
Slc35b1 |
solute carrier family 35, member B1 |
|
increases expression |
EXP |
10 |
84,069,903 |
84,076,976 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
multiple interactions |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated NFKB activator |
|
decreases expression |
EXP |
3 |
43,396,247 |
43,475,491 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
increases expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tbx19 |
T-box 19 |
|
affects response to substance |
ISO |
13 |
80,890,762 |
80,913,604 |
RGD:6480464 |
CTD |
| G |
Tbx5 |
T-box 5 |
|
decreases expression |
ISO |
12 |
37,956,658 |
38,004,255 |
RGD:6480464 |
CTD |
| G |
Tcp1 |
t-complex 1 |
|
multiple interactions |
EXP |
1 |
42,103,543 |
42,111,222 |
RGD:6480464 |
CTD |
| G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
decreases expression |
EXP |
2 |
173,594,020 |
173,611,833 |
RGD:6480464 |
CTD |
| G |
Tep1 |
telomerase associated protein 1 |
|
decreases expression |
EXP |
15 |
26,802,624 |
26,852,308 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
affects expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
EXP |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
EXP |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
EXP |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
decreases expression |
EXP |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Timm17a |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
decreases expression |
EXP |
13 |
48,297,516 |
48,309,303 |
RGD:6480464 |
CTD |
| G |
Timm44 |
translocase of inner mitochondrial membrane 44 homolog (yeast) |
|
increases expression |
EXP |
12 |
1,514,616 |
1,531,317 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
affects localization |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases response to substance |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tmem171 |
transmembrane protein 171 |
|
multiple interactions |
EXP |
2 |
29,301,092 |
29,310,650 |
RGD:6480464 |
CTD |
| G |
Tmsbl1 |
thymosin beta-like protein 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
decreases expression |
EXP |
6 |
136,196,746 |
136,210,410 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
multiple interactions |
EXP |
3 |
3,692,740 |
3,717,332 |
RGD:6480464 |
CTD |
| G |
Traip |
TRAF-interacting protein |
|
multiple interactions |
EXP |
8 |
113,220,855 |
113,240,631 |
RGD:6480464 |
CTD |
| G |
Trip10 |
thyroid hormone receptor interactor 10 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
multiple interactions |
EXP |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
increases response to substance |
EXP |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
increases expression |
EXP |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Tubb2b |
tubulin, beta 2B class IIb |
|
decreases expression |
EXP |
17 |
37,087,922 |
37,090,969 |
RGD:6480464 |
CTD |
| G |
Tubb5 |
tubulin, beta 5 class I |
|
increases expression |
EXP |
20 |
3,060,224 |
3,090,776 |
RGD:6480464 |
CTD |
| G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
|
increases expression |
ISO |
7 |
32,719,959 |
32,750,002 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
decreases expression |
EXP |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
|
increases expression |
EXP |
9 |
87,052,169 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Usf1 |
upstream transcription factor 1 |
|
decreases expression |
EXP |
13 |
87,336,705 |
87,344,466 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
decreases expression |
EXP |
4 |
161,333,661 |
161,340,447 |
RGD:6480464 |
CTD |
| G |
Vamp2 |
vesicle-associated membrane protein 2 |
|
increases expression |
EXP |
10 |
55,848,264 |
55,852,132 |
RGD:6480464 |
CTD |
| G |
Vamp3 |
vesicle-associated membrane protein 3 |
|
decreases expression |
EXP |
5 |
168,190,569 |
168,201,165 |
RGD:6480464 |
CTD |
| G |
Vamp3 |
vesicle-associated membrane protein 3 |
|
increases expression |
EXP |
5 |
168,190,569 |
168,201,165 |
RGD:6480464 |
CTD |
| G |
Wfdc18 |
WAP four-disulfide core domain 18 |
|
increases expression |
ISO |
10 |
71,930,940 |
71,933,083 |
RGD:6480464 |
CTD |
Term paths to the root
|